Pharmacogenetic Testing Market, By Technology (Polymerase Chain Reaction (PCR), Sequencing, Microarray Analysis, and Other Technologies), By Application (Cardiology, Gastroenterology, Endocrinology, Immunology & Hypersensitivity, Gynecology, Oncology, Neu

Pharmacogenetic Testing Market, By Technology (Polymerase Chain Reaction (PCR), Sequencing, Microarray Analysis, and Other Technologies), By Application (Cardiology, Gastroenterology, Endocrinology, Immunology & Hypersensitivity, Gynecology, Oncology, Neurology, and Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Biopharmaceutical Companies, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)


Pharmacogenetic testing is a technique that examines genetic variations of individuals to check their ability to metabolize and respond to drugs. It helps determine the safety and efficacy of medications for an individual based on their genetic makeup. This testing plays a pivotal role in practicing precision or personalized medicine wherein the treatment, its dosage, and duration are customized based on an individual's genetic profile. With the advancement of genomic technologies and declining costs of whole genome sequencing, the market for pharmacogenetic testing is growing rapidly worldwide.

Market Dynamics:

The global pharmacogenetic testing market is driven by rising incidence of chronic diseases requiring long term medication, growing demand for personalized healthcare, declining costs of genomic technologies, and increasing adoption of direct-to-consumer genetic testing kits. However, lack of clinical evidence supporting pharmacogenetic testing, reluctance among physicians for widespread adoption, and reimbursement issues pose challenges to the market growth. Opportunities include growing research activities in pharmacogenomics to discover new biomarkers, partnerships between pharmaceutical companies and diagnostic firms to develop companion diagnostics, and expansion into emerging Asian and Latin American countries.

Key Features of the Study:
  • This report provides in-depth analysis of the global pharmacogenetic testing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pharmacogenetic testing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Illumina, Inc, Abbott Laboratories, F. Hoffmann-La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pharmacogenetic testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacogenetic testing market
Detailed Segmentation-
  • By Technology
  • Polymerase Chain Reaction (PCR)
  • Sequencing
  • Microarray Analysis
  • Other Technologies
  • By Application
  • Cardiology
  • Gastroenterology
  • Endocrinology
  • Immunology & Hypersensitivity
  • Gynecology
  • Oncology
  • Neurology
  • Others
  • By End User
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • Others
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles:
  • Abbott Laboratories
  • Admera Health
  • Agena Bioscience
  • BiogeniQ
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Gene by Gene, Ltd.
  • Genomic Health
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Myriad Genetics, Inc.
  • OneOme, LLC
  • OPKO Health, Inc.
  • Quest Diagnostics Incorporated
  • Roche Molecular Diagnostics
  • Sonic Healthcare
  • Thermo Fisher Scientific Inc.
  • 23andMe, Inc.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Technology
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Pharmacogenetic Testing Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Pharmacogenetic Testing Market, By Technology, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Polymerase Chain Reaction (PCR)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Sequencing
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Microarray Analysis
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Other Technologies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Pharmacogenetic Testing Market, By Application, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Cardiology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Gastroenterology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Endocrinology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Immunology & Hypersensitivity
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Gynecology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Oncology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Neurology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Pharmacogenetic Testing Market, By End User, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Hospitals & Clinics
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Academic & Research Institutes
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Biopharmaceutical Companies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Pharmacogenetic Testing Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2020–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
Abbott Laboratories
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Admera Health
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Agena Bioscience
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
BiogeniQ
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Bio-Rad Laboratories, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Cepheid
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Gene by Gene, Ltd.
Genomic Health
Illumina, Inc.
Laboratory Corporation of America Holdings (LabCorp)
Myriad Genetics, Inc.
OneOme, LLC
OPKO Health, Inc.
Quest Diagnostics Incorporated
Roche Molecular Diagnostics
Sonic Healthcare
Thermo Fisher Scientific Inc.
23andMe, Inc.
10. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. Reference and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 28 figures on Pharmacogenetic Testing Market” - Global forecast to 2031

Loading...

In this report,

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings